Breast cancer screening: Review of benefits and harms, and recommendations for developing and low-income countries

Medical Oncology

Volumn 30, Issue 2, 2013, Pages

  Al Foheidi, Meteb ^a   Al Mansour, Mubarak M ^a   Ibrahim, Ezzeldin M ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b International Medical Center   (Saudi Arabia)

Author keywords

Breast cancer; Developing countries; Early detection; Guidelines; Low income countries; Screening

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADJUVANT THERAPY; BREAST CANCER; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; COST EFFECTIVENESS ANALYSIS; DENSITY; DEVELOPING COUNTRY; DIGITAL MAMMOGRAPHY; ECHOGRAPHY; ECHOMAMMOGRAPHY; GENE MUTATION; HEALTH CARE PLANNING; HEALTH SERVICE; HIGH RISK PATIENT; HUMAN; INTERPERSONAL COMMUNICATION; INTRADUCTAL CARCINOMA; LOWEST INCOME GROUP; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION HAZARD; REVIEW; SAUDI ARABIA; SYSTEMATIC REVIEW (TOPIC); BREAST TUMOR; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; MAMMOGRAPHY; METHODOLOGY; POVERTY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; MAMMOGRAPHY; POVERTY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84873742625     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0471-5     Document Type: Review

References (120)

1. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461-84.
2. Parkin DM, Ferlay J, Curado MP, et al. Fifty years of cancer incidence: Ci5 i-ix. Int J Cancer. 2010;127:2918-27.
3. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358:213-6.
4. Gakwaya A, Kigula-Mugambe JB, Kavuma A, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer. 2008;99:63-7.
5. Saudi Cancer Registry (SCR). http://www.scr.org.sa/reports/SCR2007.pdf. Accessed 7 Jan 2013.
6. Ibrahim EM, Zeeneldin AA, Sadiq BB, et al. The present and the future of breast cancer burden in the kingdom of Saudi Arabia. Med Oncol. 2008;25:387-93.
7. Babay ZA, Addar MH, Shahid K, et al. Age at menarche and the reproductive performance of Saudi women. Ann Saudi Med. 2004;24:354-6.
8. Khalid ME. The prevalence of abdominal obesity and its associated risk factors in married, non-pregnant women born and living in high altitude, southwestern, Saudi Arabia. Saudi Med J. 2007;28:1875-80.
9. Al-Hazzaa HM. Prevalence of physical inactivity in saudi arabia: a brief review. East Mediterr Health J. 2004;10:663-70.
10. Farahat FM, Joshi KP, Al-Mazrou FF. Assessment of nutritional status and lifestyle pattern among Saudi Arabian school children. Saudi Med J. 2007;28:1298-300.
11. Ibrahim EM, al-Mulhim FA, al-Amri A, et al. Breast cancer in the eastern province of Saudi Arabia. Med Oncol. 1998;15:241-7.
12. Ezzat AA, Ibrahim EM, Raja MA, et al. Locally advanced breast cancer in Saudi Arabia: high frequency of stage iii in a young population. Med Oncol. 1999;16:95-103.
13. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007;5:225-33.
14. Abulkhair OA, Al Tahan FM, Young SE, et al. The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med. 2010;30:350-7.
15. Dandash KF, Al-Mohaimeed A. Knowledge, attitudes, and practices surrounding breast cancer and screening in female teachers of Buraidah, Saudi Arabia. Int J Health Sci. 2007;1:61-71.
16. Semiglazov VF, Sagaidak VN, Moiseyenko VM, et al. Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian federation/world health organization study. Eur J Cancer. 1993;29A:2039-46.
17. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in shanghai: final results. J Natl Cancer Instit. 2002;94:1445-57.
18. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2003;(2):CD003373.
19. IARC, Working group on the evaluation of cancer-prevention strategies. In: Breast cancer screening, vol. 7. Lyon, France: IARC Press; 2002. p. 87-117.
20. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282:1270-80.
21. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977;39:2772-82.
22. Shapiro S. Periodic screening for breast cancer: the hip randomized controlled trial. Health insurance plan. J Natl Cancer Inst Monogr. 1997;(22):27-30.
23. Pisani P, Parkin DM, Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006;118:149-54.
24. Boulos S, Gadallah M, Neguib S, et al. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast. 2005;14:340-6.
25. National Cancer Institute, Canada. http://NCICcredocciwiIcancercontrol. cancer.gov/grants/abstract.asp?applid=6965060. Accessed 7 Jan 2013.
26. Miller AB, To T, Baines CJ, et al. Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Instit. 2000;92:1490-9.
27. Denewer A, Hussein O, Farouk O, et al. Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg. 2010;34:2204-10.
28. Ravert PK, Huffaker C. Breast cancer screening in women: an integrative literature review. J Am Acad Nurse Pract. 2010;22:668-73.
29. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Instit. 2000;92:1081-7.
30. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004;328:921-4.
31. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089-96.
32. Elmore JG, Armstrong K, Lehman CD, et al. Screening for breast cancer. JAMA. 2005;293:1245-56.
33. Castells X, Roman M, Romero A, et al. Breast cancer detection risk in screening mammography after a false-positive result. Cancer Epidemiol. 2013;37(1):85-90.
34. Weinstein SP, Localio AR, Conant EF, et al. Multimodality screening of high-risk women: a prospective cohort study. J Clin Oncol. 2009;27:6124-8.
35. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773-83.
36. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168-75.
37. Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50:3-14.
38. Tosteson AN, Stout NK, Fryback DG, et al. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med. 2008;148:1-10.
39. Crystal P, Strano SD, Shcharynski S, et al. Using sonography to screen women with mammographically dense breasts. AJR. 2003;181:177-82.
40. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151-63.
41. Corsetti V, Houssami N, Ferrari A, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44:539-44.
42. Corsetti V, Houssami N, Ghirardi M, et al. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up. Eur J Cancer. 2011;47:1021-6.
43. Smith RA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2011: a review of current American cancer society guidelines and issues in cancer screening. CA Cancer J Clin. 2011;61:8-30.
44. American Cancer Society. Cancer ACSG. http://www.cancer.org/acs/groups/ content/faf. Accessed 7 Jan 2013.
45. Anderson BO, Braun S, Lim S, et al. Early detection of breast cancer in countries with limited resources. Breast J. 2003;9(Suppl 2):S51-9.
46. Lenner P, Jonsson H. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen. 1997;4:6-9.
47. Alexander FE. The edinburgh randomized trial of breast cancer screening. J Natl Cancer Inst Monogr. 1997;(22):31-5.
48. Anonymous. 16-year mortality from breast cancer in the UK trial of early detection of breast cancer. Lancet. 1999;353:1909-14.
49. Tabar L, Vitak B, Chen HH, et al. Update of the Swedish two-county trial of breast cancer screening: histologic grade-specific and age-specific results. Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera. 1999;5:199-204.
50. Autier P. Breast cancer screening. Eur J Cancer. 2011;47(Suppl 3):S133-46.
51. Narod SA. On being the right size: a reappraisal of mammography trials in Canada and Sweden. Lancet. 1997;349:1846.
52. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355:129-34.
53. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011;(1):CD001877. doi: 10.1002/14651858.CD001877. pub4.
54. Anonymous. Independent UK panel on breast cancer screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778-86.
55. Harris R, Yeatts J, Kinsinger L. Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. Prev Med. 2011;53:108-14.
56. Coldman A, Phillips N, Warren L, et al. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer. 2007;120:1076-80.
57. Feig SA. Effect of service screening mammography on population mortality from breast carcinoma. Cancer. 2002;95:451-7.
58. Zahl PH, Gotzsche PC, Andersen JM, et al. Results of the two-county trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics. Dan Med Bull. 2006;53:438-40.
59. Kalager M, Zelen M, Langmark F, et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:1203-10.
60. Anonymous. Summaries for patients. Screening for breast cancer: recommendations from the U.S. Preventive services task force. Ann Intern Med. 2002;137:I47.
61. Humphrey LL, Helfand M, Chan BK, et al. Breast cancer screening: a summary of the evidence for the U.S. Preventive services task force. Ann Intern Med. 2002;137:347-60.
62. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med. 2009;151:727-37, W237-42.
63. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738-47.
64. Wai ES, D'Yachkova Y, Olivotto IA, et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer. 2005;92:961-6.
65. Goel A, Littenberg B, Burack RC. The association between the pre-diagnosis mammography screening interval and advanced breast cancer. Breast Cancer Res Treat. 2007;102:339-45.
66. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Instit. 2004;96:1832-9.
67. Miller AB, To T, Baines CJ, et al. The Canadian national breast screening study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-12.
68. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the swedish mammography screening in young women (scry) cohort. Cancer. 2011;117:714-22.
69. Weedon-Fekjaer H. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the swedish mammography screening in young women (scry) cohort. Cancer. 2012;118:1169; author reply 70-1.
70. Jorgensen KJ, Gyotzsche PC. Unclear methods in estimate of screening effect in women ages 40 to 49 years. Cancer. 2012;118:1170; author reply 70-1.
71. Mandelblatt JS, Schechter CB, Yabroff KR, et al. Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005;20:487-96.
72. Lash TL, Fox MP, Buist DS, et al. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;25:3001-6.
73. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008;26:2482-8.
74. Mandelblatt J, Saha S, Teutsch S, et al. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2003;139:835-42.
75. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med. 2011;365:1025-32.
76. Yu J, Park A, Morris E, et al. MRI screening in a clinic population with a family history of breast cancer. Ann Surg Oncol. 2008;15:452-61.
77. Liberman L. Breast cancer screening with MRI - what are the data for patients at high risk? N Engl J Med. 2004;351:497-500.
78. Lehman CD, Smith RA. The role of MRI in breast cancer screening. JNCCN. 2009;7:1109-15.
79. Grann VR, Patel PR, Jacobson JS, et al. Comparative effectiveness of screening and prevention strategies among brca1/2-affected mutation carriers. Breast Cancer Res Treat. 2011;125:837-47.
80. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-36.
81. Wright H, Listinsky J, Rim A, et al. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women. Am J Surg. 2005;190:572-5.
82. SEER. http://seer.cancer.gov/statfacts/html/breast.html. Accessed 13 Feb 2013.
83. Autier P, Boniol M, Middleton R, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol. 2011;22:1726-35.
84. Autier P, Boniol M. The incidence of advanced breast cancer in the west midlands, United Kingdom. Eur J Cancer Prev. 2012;21:217-21.
85. Shen Y, Yang Y, Inoue LY, et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Instit. 2005;97:1195-203.
86. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998-2005.
87. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-92.
88. NHS Cancer Screening Programmes. NBSPAR. http://www.cancerscreening.nhs. uk/breastscreen/publications/nhsbsp-annualreview2011.pdf. Accessed 7 Jan 2013.
89. Fallowfield LJ, Hall A. Psychosocial and sexual impact of diagnosis and treatment of breast cancer. Br Med Bull. 1991;47:388-99.
90. Berry DA, Baines CJ, Baum M, et al. Flawed inferences about screening mammography's benefit based on observational data. J Clin Oncol. 2009;27:639-40; author reply 41-2.
91. Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-60.
92. Harford JB. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol. 2011;12:306-12.
93. Ontario Health Services. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10:1-55.
94. Berrington de Gonzalez A, Berg CD, Visvanathan K, et al. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Instit. 2009;101:205-9.
95. Sigurdsson K, Sigvaldason H. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand. 2006;85:343-9.
96. Jensen AR, Madsen AH, Overgaard J. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival. Acta Oncol. 2008;47:537-44.
97. Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156:491-9.
98. Groot MT, Baltussen R, Uyl-de Groot CA, et al. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006;12(Suppl 1):S81-90.
99. Okonkwo QL, Draisma G, der Kinderen A, et al. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Instit. 2008;100:1290-300.
100. Wong IO, Kuntz KM, Cowling BJ, et al. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition markov modelling. Hong Kong Med J. 2010;16(Suppl 3):38-41.
101. Szeto KL, Devlin NJ. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy. 1996;38:101-15.
102. Somdatta P, Baridalyne N. Awareness of breast cancer in women of an urban resettlement colony. Indian J Cancer. 2008;45:149-53.
103. Yip CH, Smith RA, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer. 2008;113:2244-56.
104. Rasu RS, Rianon NJ, Shahidullah SM, et al. Effect of educational level on knowledge and use of breast cancer screening practices in Bangladeshi women. Health Care Women Int. 2011;32:177-89.
105. Ibrahim NA, Odusanya OO. Knowledge of risk factors, beliefs and practices of female healthcare professionals towards breast cancer in a tertiary institution in Lagos, Nigeria. BMC cancer. 2009;9:76.
106. Garg P, Bansal M, Garg M, et al. Creating awareness about the painless nature of early breast cancer lump is important in low-income countries. Breast J. 2010;16:101-2.
107. Hajian S, Vakilian K, Najabadi KM, et al. Effects of education based on the health belief model on screening behavior in high risk women for breast cancer, Tehran, Iran. APJCP. 2011;12:49-54.
108. Caleffi M, Ribeiro RA, Bedin AJ Jr, et al. Adherence to a breast cancer screening program and its predictors in underserved women in southern brazil. Cancer Epidemiol Biomarkers Prevent. 2010;19:2673-9.
109. Azaiza F, Cohen M, Awad M, et al. Factors associated with low screening for breast cancer in the Palestinian authority: relations of availability, environmental barriers, and cancer-related fatalism. Cancer. 2010;116:4646-55.
110. Dunn RA, Tan A, Samad I. Does performance of breast self-exams increase the probability of using mammography: evidence from Malaysia. APJCP. 2010;11:417-21.
111. Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam Med. 2011;43:248-53.
112. Gotzsche PC, Hartling OJ, Nielsen M, et al. Breast screening: the facts-or maybe not. BMJ. 2009;338:b86.
113. Bello M. Awareness is the first step in battle against breast cancer. Bull World Health Organ. 2012;90:164-5.
114. Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prevent Res (Philadelphia, Pa). 2012;5:515-21.
115. Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2012;30:1553-61.
116. Schmid SM, Eichholzer M, Bovey F, et al. Impact of body mass index on compliance and persistence to adjuvant breast cancer therapy. Breast. 2012;21:487-92.
117. Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219-29.
118. Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28:753-65.
119. Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative global summit 2007. Cancer. 2008;113:2221-43.
120. Sharma K, Costas A, Shulman LN, et al. A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol. 2012;2012:121873.